生物活性 | |||
---|---|---|---|
靶点 |
|
||
描述 | JNKs (c-jun NH2-terminal kinases) are serine/threonine-protein kinase involved in various processes such as cell proliferation, differentiation, migration, transformation and programmed cell death. Extracellular stimuli such as proinflammatory cytokines or physical stress stimulate the JNK signaling pathway. There are three distinct alternatively spliced genes (Jnk1, Jnk2, and Jnk3) that produce approximately ten different proteins. The predominant isoforms JNK1 and JNK2 are ubiquitously expressed, but JNK3 is expressed primarily in the nervous system. JNK-IN-7 is a JNK inhibitor with IC50 values of 1.54 nM, 1.99 nM, 0.75 nM to JNK1, JNK2, JNK3, respectively[3]. It also inhibits phosphorylation of c-Jun, which is a direct substrate of JNK kinase in Hela and A375 cells, with EC50s of 130nM and 244nM, respectively[3]. At the concentration of 1μM, 48h incubation of JNK-IN-7 could rescue the down-regulation of DMT-1 expression resulted by TNF[4]. At the concentrations of 1mM or 10mM, JNK-IN-7 inhibited the IL-1-stimulated activation of Pellino 1 in IL-1R cells[5]. | ||
作用机制 | JNK-IN-7 is a covalent inhibitor of JNKs[3]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.03mL 0.41mL 0.20mL |
10.13mL 2.03mL 1.01mL |
20.26mL 4.05mL 2.03mL |
参考文献 |
---|